In a meta-analysis of primary data from 40 studies including 95,617 individuals without a history of CV disease, NT-proBNP strongly predicted first-onset HF and offered augmented risk prediction for coronary heart disease (CHD) and stroke [34]. This evidence concerns the gene NPPB and coronary artery disorder.